Evidence map›Paper›PMID 16769715›Full record

ArticleThorax2006

Association between markers of emphysema and more severe chronic obstructive pulmonary disease.

P Boschetto, S Quintavalle, E Zeni, S Leprotti, A Potena, L Ballerin, A Papi, G Palladini, M Luisetti, L Annovazzi and 4 more

Open access · greenAbstract read
In one paragraph

Article in Thorax, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it, 166 citations in OpenAlex.

  1. Pooled it
  2. Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema.American journal of respiratory and critical care medicine · 2011
    Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Aryl hydrocarbon receptor deficiency causes the development of chronic obstructive pulmonary disease through the integration of multiple pathogenic mechanisms.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Is periodontitis a comorbidity of COPD or can associations be explained by shared risk factors/behaviors?International journal of chronic obstructive pulmonary disease · 2017
    Review
  14. Can we predict the prognosis of COPD with a routine blood test?International journal of chronic obstructive pulmonary disease · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Protein networks in induced sputum from smokers and COPD patients.International journal of chronic obstructive pulmonary disease · 2015
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

P BoschettoDepartment of Experimental and Clinical Medicine, University of Ferrara, Italy. bsp@unife.it
S Quintavalle
E Zeni
S Leprotti
A Potena
L Ballerin
A Papi
G Palladini
M Luisetti
L Annovazzi
P Iadarola
E De Rosa
L M Fabbri
C E Mapp
University of Ferrara · ITUniversity of Pavia · ITCenter for Translational Neurophysiology of Speech and Communication · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Modena and Reggio Emilia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe predominant emphysema phenotype is associated with more severe airflow limitation in patients with chronic obstructive pulmonary disease (COPD). A study was undertaken to investigate whether COPD patients, with or without emphysema quantitatively confirmed by high resolution computed tomography (HRCT), have different COPD severity as assessed by the BODE index (body mass index, airflow obstruction, dyspnoea, exercise performance) and inspiratory capacity to total lung capacity ratio (IC/TLC), and by different biological markers of lung parenchymal destruction.

methodsTwenty six outpatients with COPD and eight healthy non-smokers were examined. Each subject underwent HRCT scanning, pulmonary function tests, cell counts, and measurements of neutrophil elastase, matrix metalloproteinase (MMP)-9 and tissue inhibitor of metalloproteinase (TIMP)-1 in induced sputum, as well as measurement of desmosine, a marker of elastin degradation in urine, plasma and sputum.

resultsPatients with HRCT confirmed emphysema had a higher BODE index and lower IC/TLC ratio than subjects without HRCT confirmed emphysema and controls. Forced expiratory volume in 1 second (FEV(1)), FEV(1)/forced vital capacity ratio, and carbon monoxide transfer coefficient were lower, whereas the number of eosinophils, MMP-9, and the MMP-9/TIMP-1 ratio in sputum were higher in patients with emphysema. In COPD patients the number of sputum eosinophils was the biological variable that correlated positively with the HRCT score of emphysema (p = 0.04).

conclusionsThese results suggest that COPD associated with HRCT confirmed emphysema is characterised by more severe lung function impairment, more intense airway inflammation and, possibly, more serious systemic dysfunction than COPD not associated with HRCT confirmed emphysema.

Indexed as

AgedBiomarkersBody Mass IndexCell CountFemaleForced Expiratory VolumeHumansMaleMatrix Metalloproteinase 9Pulmonary Disease, Chronic ObstructivePulmonary EmphysemaSputumTissue Inhibitor of Metalloproteinase-1Tomography, X-Ray ComputedTotal Lung CapacityVital CapacityBiomarkersMatrix Metalloproteinase 9Tissue Inhibitor of Metalloproteinase-1

Identifiers

PMID16769715
PMCPMC2117071
OpenAlexW2100080030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.